Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
05/2012
05/17/2012US20120122930 1H-Benzimidazole-5-Carboxamides As Anti-Inflammatory Agents
05/17/2012US20120122920 Libraries of n-substituted-n-phenylethylsulfonamides for drug discovery
05/17/2012US20120122917 Method For Treatment Of HIV And Diseases Of Immune Dysregulation
05/17/2012US20120122909 Spiro-oxindole compounds and their uses as therapeutic agents
05/17/2012US20120122907 Novel Pyrazole Derivatives and their use as Positive Allosteric Modulators of Metabotropic Glutamate Receptors
05/17/2012US20120122895 5,6-bicyclic heteroaryl-containing urea compounds as kinase inhibitors
05/17/2012US20120122894 Inhibitors of bruton's tyrosine kinase
05/17/2012US20120122889 Small molecule inhibitors of necroptosis
05/17/2012US20120122886 Thiadiazole-substituted arylamides as p2x3 and p2x2/3 antagonists
05/17/2012US20120122883 New salts
05/17/2012US20120122879 Compounds useful as protein kinase inhibitors
05/17/2012US20120122876 Pyridopyrazinones derivatives insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes
05/17/2012US20120122868 Apaf-1 inhibitor compounds
05/17/2012US20120122860 Solid forms of sulfonamides and amino acids
05/17/2012US20120122858 Lactam compounds and their use as pharmaceuticals
05/17/2012US20120122855 Benzoxazines, benzothiazines, and related compounds having nos inhibitory activity
05/17/2012US20120122852 Tricyclic n-heteroaryl-carboxamide derivatives containing a benzimidazole unit, method for preparing same and their therapeutic use
05/17/2012US20120122843 Compounds and Their Use for Treatment of Amyloid Beta-Related Diseases
05/17/2012US20120122842 Nampt and rock inhibitors
05/17/2012US20120122838 Heterocyclic compounds and uses thereof
05/17/2012US20120122836 Polymorphic form of 1-(4--2-ethyl-benzyl)-azetidine-3-carboxylic
05/17/2012US20120122835 Poly (ADP-Ribose) Polymerase (PARP) Inhibitors
05/17/2012US20120122827 Novel derivatives of cholest-4-en-3-one oxime, pharmaceutical compositions containing them and preparation method
05/17/2012US20120122825 Use of picoplatin to treat prostate cancer
05/17/2012US20120122824 Reduction of Side Effects From Aromatase Inhibitors Used for Treating Breast Cancer
05/17/2012US20120122821 Steroid-containing sustained release intraocular implants and related methods
05/17/2012US20120122813 Composition containing oligosaccharides for the treatment/prevention of infections
05/17/2012US20120122780 Compounds, Compositions and Methods for Modulating Uric Acid Levels
05/17/2012US20120122764 Substituted carbamoylcycloalkyl acetic acid derivatives as nep
05/17/2012US20120122763 Novel tetrahydrocarbazole derivatives as ligands of g-protein coupled receptors
05/17/2012US20120122761 Methods for detecting a polymorphism in the nfkb1 gene promoter
05/17/2012US20120121743 Schisandra sphenanthera fruit extract and cosmetic, dermatological and nutraceutical compositions comprising same
05/17/2012US20120121739 Bioactive botanical cosmetic compositions and processes for their production
05/17/2012US20120121738 Bioactive botanical cosmetic compositions and processes for their production
05/17/2012US20120121737 Compositions comprising trans-tert-butyl cyclohexanol as skin irritation-reducing agent
05/17/2012US20120121729 Antitussive compositions comprising memantine
05/17/2012US20120121724 Film comprising therapeutic agents
05/17/2012US20120121721 Skin care products and compositions
05/17/2012US20120121711 Microsphere drug carrier, preparation method, composition and use thereof
05/17/2012US20120121701 Pharmaceutical composition of peptide drug and enzyme-inhibition compounds
05/17/2012US20120121695 Acoustically sensitive drug delivery particles comprising non-lamellar forming phosphatidylethanolamine
05/17/2012US20120121689 Small interfering rna delivery
05/17/2012US20120121685 Breakfast cereals containing probiotic micro organisms
05/17/2012US20120121668 Compositions for oral adminstration of active principles requiring masking of taste
05/17/2012US20120121665 Implantable or insertable medical device resistant to microbial growth and biofilm formation
05/17/2012US20120121656 Methods and compositions for protecting against neurotoxicity of a neurotoxic agent, and improving motor coordination associated with a neurodegenerative condition or disease
05/17/2012US20120121653 Novel mometasone compositions and methods of making and using the same
05/17/2012US20120121652 Complete liquid nutrition for children at the age of 1-10 years comprising probiotics
05/17/2012US20120121642 Anti-Inflammatory Hydrolysate of C. versicolor
05/17/2012US20120121606 Antibodies that immunospecifically bind to b lymphocyte stimulator protein
05/17/2012US20120121602 Novel proteins
05/17/2012US20120121601 Mammalian receptor proteins; related reagents and methods
05/17/2012US20120121594 Anti-il-6 antibodies for the treatment of arthritis
05/17/2012US20120121593 Method for determining predisposition to pulmonary infection
05/17/2012US20120121591 SELECTIVE AND POTENT PEPTIDE INHIBITORS OF Kv1.3
05/17/2012US20120121585 SILENT Fc VARIANTS OF ANTI-CD40 ANTIBODIES
05/17/2012US20120121584 Monoclonal Antibodies Against Extracellular Loops of C5aR
05/17/2012US20120121582 Modulators Of EphA2 And Ephrina1 For The Treatment Of Fibrosis-Related Disease
05/17/2012US20120121578 Methods of using immunoglobulin aggregates
05/17/2012US20120121573 Treatment of Pulmonary Vascular Remodeling With Neprilysin
05/17/2012US20120121572 New medicines for topic use based on sulfated hyaluronic acid as activating or inhibiting agent of the cytokine activity
05/17/2012US20120121571 Lysosomal Phospholipase A2 (LPLA2) Activity as a Diagnostic and Therapeutic Target for Identifying and treating Systemic Lupus Erythematosis
05/17/2012US20120121563 Specialized nutritional formula for adult patients with gastrointestinal intolerance containing probiotics
05/17/2012US20120121561 Dry whole milk preparations containing probiotic micro-organisms
05/17/2012US20120121554 Hmg-coa secondary metabolites and uses thereof
05/17/2012US20120121545 Pharmaceutical Composition For Bone Disease Treatment Or Countering Inflammation, Comprising Cartilage Stem Cells As An Active Principle
05/17/2012US20120121541 3,5-disubstituted and 3,5,7-trisubstituted-3h-oxazolo and 3h-thiazolo[4,5-d]pyrimidin-2-one compounds and prodrugs thereof
05/17/2012US20120121539 Programming Of Cells for Tolerogenic Therapies
05/17/2012US20120121530 Vasoprotective and cardioprotective antidiabetic therapy
05/17/2012US20120121527 NOVEL BIAROMATIC COMPOUNDS THAT MODULATE PPARy TYPE RECEPTORS AND COSMETIC/PHARMACEUTICAL COMPOSITIONS COMPRISED THEREOF
05/17/2012US20120121503 Inhibition Of CD69 For Treatment Of Inflammatory Conditions
05/17/2012US20120121502 Pyrimidine hydroxy amide compounds as protein deacetylase inhibitors and methods of use thereof
05/16/2012EP2453009A1 Methods of organ regeneration
05/16/2012EP2452939A2 Piperazinyl 3-aminopyrrolidine derivatives as a ccr2 antagonist
05/16/2012EP2452690A1 Carboxymethylarginine production inhibitor and collagen denaturation inhibitor
05/16/2012EP2452688A1 Use of interleukine 10 RNA transfected macrophages in anti-inflammatory therapies
05/16/2012EP2452681A1 Salts of 13a-(s)desoxytylophorinine, preparation methods and pharmaceutical compositions and uses thereof
05/16/2012EP2451842A1 Humanised antibodies to toll-like receptor 2 and uses thereof
05/16/2012EP2451788A1 Stable crystalline polymorphs of the dipotassium salt of (s) -2- {4- [2- (2, 4-diamin0-quinaz0lin-6-yl) -ethyl]-benzoylamino} -4-methylen -penta nedioic acid
05/16/2012EP2451462A1 Inhibiting inflammation with milk oligosaccharides
05/16/2012EP2451456A1 Combined preparation for use as a medicament
05/16/2012EP2451455A2 Rxr agonist compounds and methods
05/16/2012EP2183247B1 New crystalline forms of 2 -hydroxy- 3- [5- (morpholin- 4- ylmethyl) pyridin-2-yl]1h- indole- 5 -carbonitrile citrate
05/16/2012EP1864665B1 Immunosuppressive agent comprising a heterocyclic compound as active ingredient
05/16/2012EP1480993B2 Desaturase genes, enzymes encoded thereby, and uses thereof
05/16/2012CN102459577A 适合临床应用于免疫介导性疾病的、具有增强型抑制功能的调节性t细胞的体外扩增方法 Suitable for clinical application of immune-mediated diseases, with enhanced suppression function of regulatory t-cells in vitro amplification methods
05/16/2012CN102459340A 粒性白血细胞-巨噬细胞菌落-刺激因子(gm-csf)中和抗体 Granulocyte white blood cells - macrophage colony - stimulating factor (gm-csf) neutralizing antibody
05/16/2012CN102459306A Novel amide derivatives of steroidal[3,2-c]pyrazole compounds with glucocorticoid activity
05/16/2012CN102459305A 具有糖皮质激素活性的甾类[3，2-c]吡唑化合物的新衍生物 The new derivatives of steroids having corticosteroid activity [3,2-c] pyrazole compounds
05/16/2012CN102459273A 用于研究、成像以及治疗疼痛的方法和组合物 For research, imaging, and methods and compositions for the treatment of pain
05/16/2012CN102459272A 对P110δ具有选择性的为PI3K抑制剂的二环嘧啶化合物和使用方法 Selective for P110δ bicyclic pyrimidine compounds and methods of use for the PI3K inhibitor
05/16/2012CN102459268A Diazahomoadamantane derivatives and methods of use thereof
05/16/2012CN102459261A 用于治疗变性和炎性疾病的新化合物 The new compounds for treating degenerative and inflammatory diseases for
05/16/2012CN102459255A Azetidinyl diamides as monoacylglycerol lipase inhibitors
05/16/2012CN102459252A 用于治疗糖原合酶激酶3相关疾病诸如阿尔茨海默病的咪唑取代的嘧啶 For the treatment of glycogen synthase kinase 3-related diseases such as Alzheimer's disease pyrimidine substituted imidazole
05/16/2012CN102459251A 作为白三烯a4水解酶的调节剂的具有两个稠合双环杂芳基部分的化合物 Compound bicyclic heteroaryl moiety having two fused leukotriene a4 hydrolase as modulators of
05/16/2012CN102459244A 喹唑啉二酮衍生物、其制备及其多种治疗用途 Quinazoline dione derivatives, their preparation and their therapeutic uses multiple
05/16/2012CN102459240A Azetidinyl diamides as monoacylglycerol lipase inhibitors
05/16/2012CN102459237A 6-(1h-咪唑-1-基)-2-苯基喹唑啉的晶型 6- (1h- imidazol-1-yl) -2-phenyl quinazoline crystalline form
05/16/2012CN102459232A 7-aza-spiro[3.5]nonane-7-carboxylate derivatives, preparation thereof, and therapeutic use thereof
1 ... 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 ... 1272